Soluble CD23 levels are elevated in a variety of diseases including rheumatoid arthritis (joints and synovial fluids), Sjögren’s syndrome (plasma and saliva) and in systemic lupus erythematosus (systemic) patients37, 38, 39. This evidence concerns the gene FCER2 and systemic lupus erythematosus.